Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
375 GBX | +3.59% | 0.00% | +6.38% |
05-22 | MaxCyte inks deal with Legend Biotech for tech supply | AN |
05-22 | MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.38% | 484M | |
+6.88% | 219B | |
+10.63% | 192B | |
+18.16% | 142B | |
+29.70% | 111B | |
+2.09% | 65.32B | |
+14.14% | 52.45B | |
+3.01% | 49.8B | |
+4.64% | 43.43B | |
+1.45% | 35.95B |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- Transcript : MaxCyte, Inc., Q4 2021 Earnings Call, Mar 22, 2022